<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00921700</url>
  </required_header>
  <id_info>
    <org_study_id>PARIBU-022</org_study_id>
    <secondary_id>EUDRACT No. 2007-001778-10</secondary_id>
    <nct_id>NCT00921700</nct_id>
  </id_info>
  <brief_title>Analgesic Effect of Paracetamol, Paracetamol + Codeine, Ibuprofen and Their Combination</brief_title>
  <official_title>Analgesic Effect of Ibuprofen 400 mg/Paracetamol 1000 mg, Ibuprofen 400 mg/ Paracetamol 1000 mg/60 mg Codeine, and Paracetamol 1000 mg/Codeine 60 mg: A Single-dose, Randomized, Placebo-controlled and Double-blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ullevaal University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the combination of paracetamol
      (acetaminophen) and other NSAIDs with or without weak opioids can give synergistic analgesic
      effect.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Combining paracetamol and other NSAIDs could give a theoretical synergistic analgesic effect
      according to already known or assumed mechanisms of action. Synergism is defined as an
      additive or supra-additive effect not achieved by one of the drugs alone. Such synergism is
      shown in clinical studies between acetaminophen and naproxen in coxarthrosis and rheumatoid
      arthritis. Later, a significant additive effect of 100 mg diclofenac with 1 g acetaminophen
      was demonstrated in a dental pain model.

      One review article conclude that acetaminophen and NSAIDs may be appropriate to combine, and
      the combination is superior to acetaminophen, but not to NSAIDs alone. This view is contested
      by another review article which concludes that paracetamol may enhance the analgesic effect
      when added to an NSAID. In both reviews the authors also state that the clinical trials are
      too few, with different drug formulations, and different pain models not allowing definite
      conclusions.

      There seems to be a need for studies investigating the potential synergistic effects of
      paracetamol combined with another NSAID displaying similar pharmacokinetic characteristics.
      To the best of our knowledge no published study has investigated the analgesic effect of the
      combination of ibuprofen and paracetamol, ibuprofen and paracetamol + codeine versus placebo
      (i.e. negative control to adjust for possible analgesic placebo effects) and the best
      standard analgesic treatment (i.e. paracetamol + codeine) as a positive control group.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sum pain intensity SPI (0-10 Numerical Rating Scale)</measure>
    <time_frame>6 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sum pain intensity difference score (PID)</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall assessment of efficacy (4-point Verbal Rating Scale)</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effects AE (Specific reporting of AE - type, duration and severity)</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Ibuprofen + Paracetamol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single oral dose of ibuprofen 400 mg + paracetamol (acetaminophen) 1000 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ibuprofen + Paracetamol + Codeine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single oral dose of ibuprofen 400 mg + paracetamol (acetaminophen) 1000 mg + codeine 60 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Paracetamol + Codeine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single oral dose of paracetamol (acetaminophen) 1000 mg + codeine 60 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single oral dose of lactose as placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen + Paracetamol</intervention_name>
    <description>Single oral dose of ibuprofen 400 mg combined with paracetamol (acetaminophen) 1000 mg in gelatine capsules</description>
    <arm_group_label>Ibuprofen + Paracetamol</arm_group_label>
    <other_name>Ibuprofen</other_name>
    <other_name>ATC code: M01A E01</other_name>
    <other_name>Paracetamol (Acetaminophen)</other_name>
    <other_name>ATC code: N02B E01</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen + Paracetamol + Codeine</intervention_name>
    <description>Single oral dose of ibuprofen 400 mg combined with paracetamol (acetaminophen) 1000 mg and codeine 60 mg in gelatine capsules</description>
    <arm_group_label>Ibuprofen + Paracetamol + Codeine</arm_group_label>
    <other_name>Ibuprofen</other_name>
    <other_name>ATC code: M01A E01</other_name>
    <other_name>Paracetamol (Acetaminophen)</other_name>
    <other_name>ATC code: N02B E01</other_name>
    <other_name>Codeine</other_name>
    <other_name>ATC code: R05D A04</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracetamol + Codeine</intervention_name>
    <description>Single oral dose of paracetamol (acetaminophen) 1000 mg combined with codeine 60 mg in gelatine capsules</description>
    <arm_group_label>Paracetamol + Codeine</arm_group_label>
    <other_name>Paracetamol (Acetaminophen)</other_name>
    <other_name>ATC code: N02B E01</other_name>
    <other_name>Codeine</other_name>
    <other_name>ATC code: R05D A04</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Single oral dose of lactose as placebo in gelatine capsules</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Lactose</other_name>
    <other_name>CAS No: 63-42-3</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of ASA class I in need of surgical removal of impacted third molars and with
             at least moderate postoperative pain as defined by subjective score on a verbal rating
             scale after surgical removal of third molars.

        Exclusion Criteria:

          -  Females stating not suspected or not verified pregnancy after being questioned by
             investigator.

          -  Patients who have used analgesics for 3 days prior to the day of surgery.

          -  Patients with known active gastrointestinal bleeding or ulcer.

          -  Patients with any known hypersensitivity to NSAIDs.

          -  Patients with other drug treatment than contraceptives.

          -  Patients smoking before taking the test-drug or during the observation period.

          -  Drug addicts or rehabilitated drug addicts.

          -  Patients with surgery time exceeding 60 minutes

          -  Peroperative complications such as profuse bleeding or perforation to the maxillary
             sinus requiring additional drug treatment during or after the surgical removal of the
             third molar.

          -  Postoperative complications such as extended bleeding, nausea and regurgitation during
             the observation period.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lasse A Skoglund, DDS, DSci</last_name>
    <role>Study Director</role>
    <affiliation>University of Oslo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gaute Lyngstad, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oslo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ullevaal University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>NO-0407</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <reference>
    <citation>Seideman P. Additive effect of combined naproxen and paracetamol in rheumatoid arthritis. Br J Rheumatol. 1993 Dec;32(12):1077-82.</citation>
    <PMID>8252318</PMID>
  </reference>
  <reference>
    <citation>Seideman P, Samuelson P, Neander G. Naproxen and paracetamol compared with naproxen only in coxarthrosis. Increased effect of the combination in 18 patients. Acta Orthop Scand. 1993 Jun;64(3):285-8.</citation>
    <PMID>8322582</PMID>
  </reference>
  <reference>
    <citation>Breivik EK, Barkvoll P, Skovlund E. Combining diclofenac with acetaminophen or acetaminophen-codeine after oral surgery: a randomized, double-blind single-dose study. Clin Pharmacol Ther. 1999 Dec;66(6):625-35.</citation>
    <PMID>10613619</PMID>
  </reference>
  <reference>
    <citation>Rømsing J, Møiniche S, Dahl JB. Rectal and parenteral paracetamol, and paracetamol in combination with NSAIDs, for postoperative analgesia. Br J Anaesth. 2002 Feb;88(2):215-26. Review.</citation>
    <PMID>11878655</PMID>
  </reference>
  <reference>
    <citation>Hyllested M, Jones S, Pedersen JL, Kehlet H. Comparative effect of paracetamol, NSAIDs or their combination in postoperative pain management: a qualitative review. Br J Anaesth. 2002 Feb;88(2):199-214. Review.</citation>
    <PMID>11878654</PMID>
  </reference>
  <reference>
    <citation>Skoglund LA, Skjelbred P, Fyllingen G. Analgesic efficacy of acetaminophen 1000 mg, acetaminophen 2000 mg, and the combination of acetaminophen 1000 mg and codeine phosphate 60 mg versus placebo in acute postoperative pain. Pharmacotherapy. 1991;11(5):364-9.</citation>
    <PMID>1745622</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 15, 2009</study_first_submitted>
  <study_first_submitted_qc>June 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2009</study_first_posted>
  <last_update_submitted>March 29, 2016</last_update_submitted>
  <last_update_submitted_qc>March 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Lasse Ansgar Skoglund</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Paracetamol</keyword>
  <keyword>Acetaminophen</keyword>
  <keyword>Ibuprofen</keyword>
  <keyword>Pain</keyword>
  <keyword>Postoperative pain</keyword>
  <keyword>third molar</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Codeine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

